DK1372636T3 - Metronomisk dosering af taxaner til hæmning af tumorvækst - Google Patents

Metronomisk dosering af taxaner til hæmning af tumorvækst

Info

Publication number
DK1372636T3
DK1372636T3 DK02723255T DK02723255T DK1372636T3 DK 1372636 T3 DK1372636 T3 DK 1372636T3 DK 02723255 T DK02723255 T DK 02723255T DK 02723255 T DK02723255 T DK 02723255T DK 1372636 T3 DK1372636 T3 DK 1372636T3
Authority
DK
Denmark
Prior art keywords
taxanes
tumor growth
inhibit tumor
metronomic dosing
metronomic
Prior art date
Application number
DK02723255T
Other languages
Danish (da)
English (en)
Inventor
Joseph Fargnoli
William C Rose
Pamela Trail
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1372636T3 publication Critical patent/DK1372636T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
DK02723255T 2001-02-28 2002-02-26 Metronomisk dosering af taxaner til hæmning af tumorvækst DK1372636T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28

Publications (1)

Publication Number Publication Date
DK1372636T3 true DK1372636T3 (da) 2006-11-06

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02723255T DK1372636T3 (da) 2001-02-28 2002-02-26 Metronomisk dosering af taxaner til hæmning af tumorvækst

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
NO20033809D0 (no) 2003-08-27
SK10332003A3 (sk) 2005-03-04
ES2211374T1 (es) 2004-07-16
CA2439299A1 (en) 2002-09-06
CZ20032232A3 (en) 2004-06-16
BG108167A (en) 2004-09-30
JP2004538253A (ja) 2004-12-24
IL157356A0 (en) 2004-02-19
PE20020955A1 (es) 2002-10-30
ZA200306450B (en) 2004-11-19
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
WO2002067928A2 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
IS6924A (is) 2003-08-22
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
UY27185A1 (es) 2002-09-30
ES2211374T3 (es) 2007-03-01
KR20030086276A (ko) 2003-11-07
CN1533273A (zh) 2004-09-29
RU2003129233A (ru) 2005-02-10
EP1372636B1 (en) 2006-06-28
PT1372636E (pt) 2006-09-29
NO20033809L (no) 2003-10-23
CY1105468T1 (el) 2010-04-28
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
HRP20030775A2 (en) 2005-02-28
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
HUP0402115A2 (hu) 2005-02-28
EE200300413A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
DK1716119T3 (da) Analoger af benzoquinonholdige ansamyciner til behandling af cancer
DK1353668T3 (da) Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
ATE488224T1 (de) Aerosol-formulierungen von diisobutyryl apomorphine
DE60220059D1 (de) Chitosanzusammensetzungen zur entklebung von lacken
DK1691607T3 (da) Anvendelse af N-arylhydrazinderivater til bekæmpelse af skadedyr
DE60204093D1 (de) Substanzgemisch von Triphenylamindimeren
ATE427953T1 (de) Fondaparinux- natrium zusammenstellung von hoher reinheit
EP1727065A4 (en) Event sequencer
DK1996744T3 (da) Fremgangsmåder til antimikrobiel coating
DK1206274T3 (da) Anvendelse af interleukin-18-inhibitorer til hæmning af tumormetastase
ATE365455T1 (de) Aminoacetonitril-verbindungen zur bekämpfung von endoparasiten
DK1372636T3 (da) Metronomisk dosering af taxaner til hæmning af tumorvækst
PT1429628E (pt) Mistura de micronutrientes contendo bases
ATE363906T1 (de) Aromatase hemmung zur steigerung der implantationsrate
ATE423549T1 (de) Injizierbare darreichungsform von flupirtin
DE602004019084D1 (de) Modulierung der osteoblast-aktivität durch fhl2
DK1606246T3 (da) Fremgangsmåde til fremstilling af 2-cyan-3-hydroxy-N-(phenyl)but-2-enamider
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DK1706417T3 (da) Anvendelse pollenisolerede proteiner til inhibering af anthraxtoxinaktivitet
SI1372636T1 (sl) Metronomsko odmerjanje taksanov za inhibiranje tumorske rasti
FR2847420B1 (fr) Debroussailleuse de type perfectionne
GB0102053D0 (en) Blocks of soil enhancing substances to aid the growing of crops
EP1774721A4 (en) PROPAGATION OF MINIMUM GUARANTEED PROGRAMMING RATES
ATA332001A (de) Badeteichanlage
HK1060051A (en) Metronomic dosing of taxanes for inhibiting tumor growth